COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Risk of COVID-19 for cancer patients

(2020) Yang Xia et al.   LANCET ONCOLOGY

Risk of COVID-19 for patients with cancer

(2020) Hanping Wang et al.   LANCET ONCOLOGY

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

COVID-19 in persons with chronic myeloid leukaemia

(2020) Weiming Li et al.   LEUKEMIA

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

(2020) Robert Zeiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

(2020) Massimo Breccia et al.   LEUKEMIA

Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib

(2019) Elena Maria Elli et al.   Frontiers in Oncology

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

(2017) Srdan Verstovsek et al.   Journal of Hematology & Oncology

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

(2016) C N Harrison et al.   LEUKEMIA

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS